Displacement of warfarin from human albumin by diazoxide and ethacrynic, mefenamic, and nalidixic acids.
D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects; D003981:Diazoxide / Q000494:pharmacology*; D004976:Ethacrynic Acid / Q000494:pharmacology*; D006801:Humans; D009268:Nalidixic Acid / Q000494:pharmacology*; D011485:Protein Binding / Q000187:drug effects; D012709:Serum Albumin / Q000378:metabolism*; D014859:Warfarin / Q000097:blood / Q000378:metabolism*; D062367:ortho-Aminobenzoates / Q000494:pharmacology*
D000893:Anti-Inflammatory Agents; D012709:Serum Albumin; D062367:ortho-Aminobenzoates; D009268:Nalidixic Acid; D014859:Warfarin; D004976:Ethacrynic Acid; D003981:Diazoxide